Business Context and Reporting Period
This Form 8-K is a current report filed by Marathon Patent Group, Inc. (the "Company") on August 15, 2017. The filing discloses the entry into material definitive agreements regarding a private placement of securities. The Company is incorporated in Nevada and identifies as an emerging growth company.
Key Financial Metrics and Transaction Details
The filing details a capital raise rather than operational financial results. Key transaction metrics include:
- Capital Raised: $3,503,500 in the initial closing of a potential $5,500,000 offering.
- Instrument: 5% secured convertible promissory notes due May 14, 2018.
- Interest Rate: 5% per annum, payable in cash at maturity or upon conversion.
- Warrants Issued: Warrants to purchase up to 17,517,500 shares of common stock.
- Warrant Exercise Price: $0.30 per share.
- Warrant Term: Five years, exercisable after six months from issuance.
- Conversion Price: Lesser of $0.20 per share or the closing bid price the day prior to conversion (subject to a $0.10 floor).
The filing text does not provide clear values for the Company's current revenue, profit, cash flow, operating margins, total debt, or liquidity positions outside of this specific transaction.
Material Changes and Agreements
The primary material change is the execution of a Unit Purchase Agreement with accredited investors. Key terms include:
- Beneficial Ownership Limitations: Conversion and exercise are subject to a 4.99% beneficial ownership limitation, which may be increased to 9.99% with 61 days' notice.
- Aggregate Limit: The cumulative shares issuable upon conversion of notes and exercise of warrants may not exceed 19.99% of outstanding common stock without shareholder approval.
- Prepayment: The Company cannot prepay or redeem the notes without the holder's prior written consent.
- Registration Rights: The Company must file a registration statement within 30 days of closing and use best efforts to have it declared effective within 90 days. Monetary penalties apply for failure to comply.
Guidance, Outlook, and Risks
The filing includes standard forward-looking statement disclaimers regarding operating results and future prospects. Specific risks and contingencies identified include:
- Dilution Risk: Significant potential dilution to existing shareholders upon conversion of notes and exercise of warrants.
- Registration Risk: The Company faces monetary penalties if it fails to file or maintain an effective registration statement for the resale of securities.
- Liquidity Constraints: The notes are non-prepayable without consent, limiting the Company's ability to manage debt repayment timing.
- Market Risk: The conversion price is tied to market prices, introducing variability in the number of shares issued upon conversion.
Investor Verification Checklist
- Verify the total number of shares outstanding to calculate the precise dilution impact of the 19.99% aggregate limit.
- Confirm the current market price of the common stock to assess the immediate conversion incentive (conversion price floor of $0.10 vs. market price).
- Review the Company's cash position to determine if it can service the 5% interest payments and principal repayment due in May 2018.
- Check the status of the registration statement filing required within 30 days of the August 14, 2017 closing.
- Examine the full text of the Unit Purchase Agreement (Exhibit 10.1) for additional covenants or default provisions not summarized in the 8-K.